_1531742103227.png?format=webp&height=120&width=120){kind=logo}
Microba - About the company
Microba is a public company based in Brisbane (Australia), founded in 2017 by Gene Tyson. It operates as a Developer of microbiome-based drug discovery platform. Microba has raised $2.85M in funding from Macrogen. The company has 547 active competitors, including 201 funded and 127 that have exited. Its top competitors include companies like Alnylam, Spark Therapeutics and Forge Biologics.
Company Details
Developer of microbiome-based drug discovery platform. The company uses human data and leading informatics approaches to connect microbial genotype to the human phenotype. It develops a pipeline for inflammatory bowel disease and Immuno-oncology diseases.
- Website
- microba.com
- Social
- Email ID
- *****@microba.com
- Phone Number
- +61 **********
Key Metrics
Founded Year
2017
Location
Brisbane, Australia
Stage
Public
Total Funding
$2.85M in 3 rounds
Latest Funding Round
Ranked
119th among 547 active competitors
Employee Count
100 as on Sep 30, 2026
Investment & Acquisitions
Exit Details
Public
Microba's IPO details
Microba got listed on Apr 05, 2022.
Click here to take a look at Microba's IPO in detail
Sign up to download Microba's company profile
Microba's funding and investors
Microba has raised a total funding of $2.85M over 3 rounds. Its first funding round was on Jun 12, 2019. Its latest funding round was a Post IPO round on Jun 23, 2025 for $*****. 1 investor participated in its latest round. Microba has 8 institutional investors.
Here is the list of recent funding rounds of Microba:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 23, 2025 | 5702263 | Post IPO | 4364196 | 9672394 | 3548090 | 9044828 |
Jun 27, 2023 | 9935451 | Grant (prize money) | 9177597 | 9214981 | 2472171 | |
Jun 12, 2019 | 9945803 | Series A | 4851584 | 6970418 | 5931219 |
Access funding benchmarks and valuations. Sign up today!View details of Microba's funding rounds and investors
Microba's founders and board of directors
Founder? Claim ProfileThe founders of Microba is Gene Tyson.
Here are the details of Microba's key team members:
- Gene Tyson: Founder & Director of Microba. Contact Info: 2 email addresses
- Blake Wills: CEO of Microba. Contact Info: 2 email addresses
View details of Microba's Founder profiles and Board Members
Microba's employee count trend
Microba has 100 employees as of Sep 26. Here is Microba's employee count trend over the years:
Uncover Microba's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Microba's Competitors and alternates
Top competitors of Microba include Alnylam, Spark Therapeutics and Forge Biologics. Here is the list of Top 10 competitors of Microba, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alnylam 2002, Cambridge (United States), Public | Developer of RNA interference-based therapeutics for multiple disorders | $17M | 79/100 | |
2nd | Spark Therapeutics 2013, Philadelphia (United States), Acquired | Developer of gene therapy for rare diseases | $82.8M | 73/100 | |
3rd |  Forge Biologics 2020, Columbus (United States), Acquired | Developer of gene therapeutic solutions for treating multiple diseases | $330M | 70/100 | |
4th |  Insitro 2018, San Francisco (United States), Series C | Developer of machine learning platform for drug discovery and development | $643M | 70/100 | |
5th |  Strand Therapeutics 2017, Cambridge (United States), Series B | Provider of platform to deliver mRNA therapeutics for multi functional treatments | $256M | 69/100 | |
6th | Ultragenyx 2010, Novato (United States), Acquired | Developer of therapeutics for the treatment of rare and ultra-rare metabolic diseases | $135M | 69/100 | |
7th | _1560516450043.png?devicePixelRatio=2&height=30&width=30){kind=logo} Passage Bio 2017, Philadelphia (United States), Public | Developer of gene therapies for CNS rare diseases | $226M | 69/100 | |
8th | ElevateBio 2018, Cambridge (United States), Series D | Provider of transnational research for portfolio of cell and gene therapy | $1.25B | 68/100 | |
9th | Krystal Biotech 2015, Pittsburgh (United States), Public | Developer of genetic medicines to treat rare diseases | $11.3M | 67/100 | |
10th | Sirnaomics 2007, Gaithersburg (United States), Public | Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease | $267M | 67/100 | |
119th | Developer of microbiome-based drug discovery platform | $2.85M | 50/100 |
_1531742103227.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Microba's competitors? Click here to see the top ones
Microba's Investments and acquisitions
Microba has acquired Invivo Healthcare. Microba has not made any investments as of now.News related to Microba
Filter this list•
Medical testing group Microba raises $14.5m with Sonic Healthcare taking lion’s share
Business News Australia Pty Ltd•Jun 23, 2025•Microba, Sonic Healthcare
•
Microba Announces Groundbreaking GI Study Results from More Than 4,600 PatientsBusiness Wire•May 16, 2025•Microba
•
Microba announces historical results of gastrointestinal study with more than 4,600 patientsBusiness Wire•May 16, 2025•Microba
•
•
•
Australia's MicroVa Concludes First Distributor Agreement with Sonic HealthcareBusiness Wire•Jul 06, 2023•Microba, Sonic Healthcare
•
First Distribution Agreement Executed with Sonic HealthcareFinancial Post•Jul 05, 2023•Microba, Sonic Healthcare, Dhm
•
•
•
Mainz Biomed, Microba Life Sciences Partner to Develop Pancreatic Cancer Screening TestGenomeWeb•May 10, 2023•Mainz BioMed, Microba
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Microba
Explore our recently published companies
- SRITECH - Nagpur based, 1995 founded, Unfunded company
- Witte Werbetechnik - Amelinghausen based, Unfunded company
- Nexarcane Forensics & Technology - Bengaluru based, 2024 founded, Unfunded company
- Parna Creations - Shivamogga based, 2023 founded, Unfunded company
- CITYX Super App - Bengaluru based, 2021 founded, Unfunded company
- Promic Svasthya - Mysuru based, 2020 founded, Unfunded company
